[Phlebography of the lower limbs: comparative trial of iopromide 370 and ioxaglate 320 mgI/ml].
Twenty patients received an injection of either iopromide 370 (10 patients) a new nonionic contrast medium, or ioxaglate 320 (10 patients) the ionic low osmolar contrast medium, in a randomized prospective trial, for phlebography of the lower limbs. A concentration of 320 mgI/ml is prescribed (more often) than 370 mgI/ml for this examination in France, where a concentration of about 300 mgI/ml is recommended. We decided to compare iopromide 370 because in some clinical situations (varicose veins, very tall patients...) this concentration may be necessary. This study demonstrates the good safety of iopromide 370, comparable to ioxaglate 320 mgI/ml, in spite of its higher concentration.
Lasjaunias
P
P
D003287:Contrast Media; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007472:Iohexol / Q000009:adverse effects / Q000031:analogs & derivatives; D007485:Ioxaglic Acid / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010690:Phlebography; D016032:Randomized Controlled Trials as Topic; D013924:Thrombophlebitis / Q000000981:diagnostic imaging*
D003287:Contrast Media; D007472:Iohexol; C038192:iopromide; D007485:Ioxaglic Acid
Phlébographie des membres inférieurs: essai comparatif de l'iopromide 370 et de l'ioxaglate 320 mgI/ml.